Reglagene Expands to Houston and Joins TMC’s Accelerator for Cancer Therapeutics
In a move that will speed development of Reglagene’s RGN6024 therapy into the clinic, Reglagene announces the expansion of its research and development facilities and team to Houston.
Click to Learn More
Read the full article on NewsWires.